Synthesis and biological assay of erlotinib analogues and BSA-conjugated erlotinib analogue

Ramalingam Boobalan, Kuang Kai Liu, Jui-I Chao*, Chinpiao Chen

*Corresponding author for this work

研究成果: Article同行評審

4 引文 斯高帕斯(Scopus)

摘要

A series of erlotinib analogues that have structural modification at 6,7-alkoxyl positions is efficiently synthesized. The in vitro anti-tumor activity of synthesized compounds is studied in two non-small cell lung cancer (NSCLC) cell lines (A549 and H1975). Among the synthesized compounds, the iodo compound 6 (ETN-6) exhibits higher anti-cancer activity compared to erlotinib. An efficient method is developed for the conjugation of erlotinib analogue-4, alcohol compound, with protein, bovine serum albumin (BSA), via succinic acid linker. The in vitro anti-tumor activity of the protein attached erlotinib analogue, 8 (ETN-4-Suc-BSA), showed stronger inhibitory activity in both A549 and H1975 NSCLC cell lines.

原文English
頁(從 - 到)1784-1788
頁數5
期刊Bioorganic and Medicinal Chemistry Letters
27
發行號8
DOIs
出版狀態Published - 1 一月 2017

指紋 深入研究「Synthesis and biological assay of erlotinib analogues and BSA-conjugated erlotinib analogue」主題。共同形成了獨特的指紋。

引用此